The revisions to the ACO REACH model are expected to add predictability and stability while advancing health equity.
CMS announced changes for 2024 to its latest accountable care organization (ACO) model, ACO Realizing Equity, Access, and Community Health (REACH). The revisions were in response to stakeholder feedback and are expected to improve the test model by adding predictability and stability, and advancements for health equity, according to CMS.
In a statement, Clif Gaus, ScD, president and CEO of National Association of ACOs (NAACOS), expressed appreciation for the improvements to the model. In May 2023, NAACOS had published recommendations to improve the model that the organization had shared with CMS.
ACO REACH was created to replace the Global and Professional Direct Contracting model and put a strong emphasis on health equity. ACOs in the model have to develop a plan for how they identify health disparities in their community and specific actions to address them. This year is the first year of the model, which is slated to run through 2026.
The changes fall into 3 categories:
“We believe these changes will satisfy many concerns and stabilize future participation,” Gaus said.
NAACOS is also encouraging CMS to add features of ACO REACH into the Medicare Shared Savings Program (MSSP), which is the permanent ACO track. In July, the organization published that it had been advocating for CMS to offer a full-risk track in MSSP to provide a better bridge to the ACO REACH model. NAACOS is calling this suggested track Enhanced Plus.
“Enhanced Plus could imbed some elements only available in Innovation Center models into MSSP, allowing more ACOs to innovate themselves and deliver higher quality patient care,” David Pittman, director, communications and regulatory affairs, NAACOS, wrote in a blog post. “In ACO REACH, providers are allowed to make home visits more easily to patients after their discharge from a hospital, provide home visits for chronic care management to help with high-needs patients, and offer cost sharing support, among other waivers.”
CMS did include a request for comment on the idea of a higher risk track in MSSP as part of the proposed Medicare Physician Fee Schedule rule, he noted.
“Using MSSP as a chassis for innovation while infusing lessons learned from Innovation Center models into a permanent program is another path for stabilizing and growing participation in ACOs,” Gaus said.
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
USPSTF Lowers Age for Biennial Mammograms to 40, Citing Early Detection Benefit
April 30th 2024The USPSTF lowered the recommended starting age for mammograms from 50 to 40 years, citing moderate benefits for early detection in this age group. Disparities persist, especially for Black women, highlighting the need for improved access to health care and social support.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
T-Cell Exhaustion in CLL: Allogeneic CAR T Trial Reaching Patients With Unmet Need
April 30th 2024"Off the shelf" CAR T-cell therapies could offer a solution in chronic lymphocytic leukemia, where T-cell exhaustion creates treatment challenges. This article will appear in the May 2024 issue of Evidence-Based Oncology.
Read More